Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-28T00:17:06.988Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (January 2008)

Published online by Cambridge University Press:  01 May 2008

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 11 , Issue 5 , May 2008 , e9
Copyright
Copyright © Cambridge University Press 2008

References

1.Abukhdeir, AM, Vitolol, MI, Argani, P, De Marzo, AM, Karakas, B, Konishi, H, Gustin, JP, Lauring, J, Garay, JP, Pendleton, C, Konishi, Y, Blair, BG, Brenner, K, Garrett-Mayer, E, Carraway, H, Bachman, KE, Park, BH. Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc Natl Acad Sci USA 2008; 105: 288–293.CrossRefGoogle ScholarPubMed
2.Allred, DC, Wu, Y, Mao, S, Nagtegaal, ID, Lee, S, Perou, CM, Mohsin, SK, O’Connell, P, Tsimelzon, A, Medina, D. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 2008; 14: 370–378.CrossRefGoogle ScholarPubMed
3.Arendt, LM, Schuler, LA. Prolactin drives estrogen receptor-α-dependent ductal expansion and synergizes with transforming growth factor-α to induce mammary tumors in males. Am J Pathol 2008; 172: 194–202.CrossRefGoogle ScholarPubMed
4.Arlander, SJH, Greene, BT, Innes, CL, Paules, RS. DNA protein kinase-dependent G(2) checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells. Cancer Res 2008; 68: 89–97.CrossRefGoogle ScholarPubMed
5.Begg, CB, Haile, RW, Borg, A, Malone, KE, Concannon, P, Thomas, DC, Langholz, B, Bernstein, L, Olsen, JH, Lynch, CF, Anton-Culver, H, Capanu, M, Liang, XL, Hummer, AJ, Sima, C, Bernstein, JL. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008; 299: 194–201.CrossRefGoogle ScholarPubMed
6.Bollet, MA, Servant, N, Neuvial, P, Decraene, C, Lebigot, I, Meyniel, JP, De Rycke, Y, Savignoni, A, Rigaill, G, Hupe, P, Fourquet, A, Sigal-Zafrani, B, Barillot, E, Thiery, JP. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. J Natl Cancer Inst 2008; 100: 48–58.CrossRefGoogle ScholarPubMed
7.Brantley-Sieders, DM, Zhuang, G, Hicks, D, Bin Fang, W, Hwang, Y, Cates, JMM, Coffman, K, Jackson, D, Bruckheirner, E, Muraoka-Cook, RS, Chen, J. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 2008; 118: 64–78.CrossRefGoogle ScholarPubMed
8.Bretschneider, N, Brand, H, Miller, N, Lowery, AJ, Kerin, MJ, Gannon, F, Denger, S. Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor α-dependent manner. Cancer Res 2008; 68: 106–114.CrossRefGoogle Scholar
9.Bultman, SJ, Herschkowitz, JI, Godfrey, V, Gebuhr, TC, Yaniv, M, Perou, CM, Magnuson, T. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 2008; 27: 460–468.CrossRefGoogle ScholarPubMed
10.Caldon, C, Lee, C, Sutherland, R, Musgrove, E. Wilms’ tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene 2008; 27: 126–138.CrossRefGoogle ScholarPubMed
11.Cascio, S, Bartella, V, Auriemma, A, Johannes, GJ, Russo, A, Giordano, A, Surmacz, E. Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1α. Oncogene 2008; 27: 540–547.CrossRefGoogle ScholarPubMed
12.Chakraborty, G, Jain, S, Kundu, GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 2008; 68: 152–161.CrossRefGoogle ScholarPubMed
13.Chang, TW, Chen, CC, Chen, KY, Su, JH, Chang, JH, Chang, MC. Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells. Oncogene 2008; 27: 332–338.CrossRefGoogle ScholarPubMed
14.Debies, MT, Gest, SA, Mathers, JL, Mikse, OR, Leonard, TL, Moody, SE, Chodosh, LA, Cardiff, RD, Gunther, EJ. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19(Arf)/p53 pathway lesions but not p16(Ink4a) loss. J Clin Invest 2008; 118: 51–63.CrossRefGoogle Scholar
15.Eckstein, N, Servan, K, Girard, L, Cai, D, von Jonquieres, G, Jaehde, U, Kassack, MU, Gazdar, AF, Minna, JD, Royer, HD. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J Biol Chem 2008; 283: 739–750.CrossRefGoogle ScholarPubMed
16.Frankel, LB, Christoffersen, NR, Jacobsen, A, Lindow, M, Krogh, A, Lund, AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283: 1026–1033.CrossRefGoogle ScholarPubMed
17.Frietze, S, Lupien, M, Silver, PA, Brown, M. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res 2008; 68: 301–306.CrossRefGoogle ScholarPubMed
18.Gao, BN, Xie, XJ, Huang, CX, Shames, DS, Chen, TTL, Lewis, CM, Bian, AH, Zhang, BF, Olopade, OI, Garber, JE, Euhus, DM, Tomlinson, GE, Minna, JD. RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res 2008; 68: 22–25.CrossRefGoogle ScholarPubMed
19.Husemann, Y, Geigl, JB, Schubert, F, Musiani, P, Meyer, M, Burghart, E, Forni, G, Eils, R, Fehm, T, RiethmUller, G, Klein, CA. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13: 58–68.CrossRefGoogle ScholarPubMed
20.Maraqa, L, Cummings, M, Peter, MB, Shaaban, AM, Horgan, K, Hanby, AM, Speirs, V. Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen. Clin Cancer Res 2008; 14: 405–411.CrossRefGoogle ScholarPubMed
21.Meijnen, P, Peterse, JL, Antonini, N, Rutgers, E, de Vijver, MJ. Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 2008; 98: 137–142.CrossRefGoogle ScholarPubMed
22.Morishige, M, Hashimoto, S, Ogawa, E, Toda, Y, Kotani, H, Hirose, M, Wei, S, Hashimoto, A, Yamada, A, Yano, H, Mazaki, Y, Kodama, H, Nio, Y, Manabe, T, Wada, H, Kobayashi, H, Sabe, H. GeP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 2008; 10: 85–U70.CrossRefGoogle ScholarPubMed
23.Newman, SP, Foster, PA, Stengel, C, Day, JM, Ho, YT, Judde, JG, Lassalle, M, Prevost, G, Leese, MP, Potter, BVL, Reed, MJ, Purohit, A. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells. Clin Cancer Res 2008; 14: 597–606.CrossRefGoogle ScholarPubMed
24.Richard, S, Vogel, G, Huot, ME, Guo, T, Muller, WJ, Lukong, KE. Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene 2008; 27: 548–556.CrossRefGoogle ScholarPubMed
25.Saal, LH, Gruvberger-Saal, SK, Persson, C, Loevgren, K, Jumppanen, M, Staaf, J, Jonsson, G, Pires, MM, Maurer, M, Holm, K, Koujak, S, Subramaniyam, S, Vallon-Christersson, J, Olsson, H, Su, T, Memeo, L, Ludwig, T, Ethier, SP, Krogh, M, Szabolcs, M, Murty, VV, Isola, J, Hibshoosh, H, Parsons, R, Borg, A. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 2008; 40: 102–107.CrossRefGoogle ScholarPubMed
26.Shen, Q, Uray, IP, Li, Y, Krisko, TI, Strecker, TE, Kim, HT, Brown, PH. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene 2008; 27: 366–377.CrossRefGoogle ScholarPubMed
27.Storci, G, Sansone, P, Trere, D, Tavolari, S, Taffurelli, M, Ceccarelli, C, Guarnieri, T, Paterini, P, Pariali, M, Montanaro, L, Santini, D, Chieco, P, Bonafe, M. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008; 214: 25–37.CrossRefGoogle ScholarPubMed
28.Tan, BK, Tan, LK, Yu, K, Tan, PH, Lee, M, Sii, LH, Wong, CY, Ho, GH, Yeo, AWY, Chow, PKH, Koong, HN, Yong, WS, Lim, DTH, Ooi, L, Soo, KC, Tan, P. Clinical validation of a customized multiple signature microarray for breast cancer. Clin Cancer Res 2008; 14: 461–469.CrossRefGoogle ScholarPubMed
29.Tavazoie, SF, Alarcon, C, Oskarsson, T, Padua, D, Wang, QQ, Bos, PD, Gerald, WL, Massague, J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147–U3.CrossRefGoogle ScholarPubMed
30.Yang, L, Huang, JH, Ren, XB, Gorska, AE, Chytil, A, Aakre, M, Carbone, DP, Matrisian, LM, Richmond, A, Lin, PC, Mosesl, HL. Abrogation of TGF β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008; 13: 23–35.CrossRefGoogle ScholarPubMed